CoreCap Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$503K Sell
1,264
-161
-11% -$70.3K 0.01% 542
2026
Q1
$657K Buy
1,425
+416
+41% +$210K 0.02% 459
2025
Q4
$571K Sell
1,009
-2,153
-68% -$1.15M 0.02% 487
2025
Q3
$1.41M Buy
3,162
+861
+37% +$413K 0.05% 302
2025
Q2
$1.25M Buy
2,301
+426
+23% +$223K 0.05% 306
2025
Q1
$929K Sell
1,875
-439
-19% -$243K 0.04% 342
2024
Q4
$1.21M Sell
2,314
-7,804
-77% -$4.06M 0.06% 301
2024
Q3
$4.97M Buy
10,118
+9,068
+864% +$4.22M 0.23% 78
2024
Q2
$467K Sell
1,050
-426
-29% -$170K 0.05% 234
2024
Q1
$589K Buy
1,476
+570
+63% +$215K 0.03% 368
2023
Q4
$306K Sell
906
-3,197
-78% -$953K 0.02% 447
2023
Q3
$1.2M Buy
+4,103
New +$1.28M 0.09% 213
2022
Q4
$320K Buy
+1,206
New +$294K 0.02% 441
2022
Q3
Sell
-224
Closed -$45K 1291
2022
Q2
$45K Buy
+224
New +$52.6K ﹤0.01% 977
2022
Q1
Sell
-3,932
Closed -$1.41M 1294
2021
Q4
$1.41M Buy
+3,932
New +$1.35M 0.09% 173

Other funds holding ISRG

CoreCap Advisors's ISRG Position: Q2 2026 in Review

CoreCap Advisors reduced its Intuitive Surgical (ISRG) stake by 11% in Q2 2026, selling an estimated $70.3K and leaving 1,264 shares worth $503K. The position accounts for 0.01% of the portfolio, ranked #542.

CoreCap Advisors first reported a position in ISRG in Q4 2021 and has held it in 15 quarters since. The position peaked at $4.97M in Q3 2024. 645 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • CoreCap Advisors held 1,264 shares of Intuitive Surgical worth $503K as of Q2 2026.
  • CoreCap Advisors sold 161 Intuitive Surgical shares in Q2 2026, an estimated $70.3K.
  • Intuitive Surgical made up 0.01% of CoreCap Advisors's portfolio in Q2 2026, its #542 holding.
  • CoreCap Advisors first reported a position in Intuitive Surgical in Q4 2021 and has held it in 15 quarters since.
  • CoreCap Advisors's Intuitive Surgical position peaked at $4.97M in Q3 2024.
  • 645 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.